The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
EMA alerts HCPs after vials of falsified Herceptin identified
16th April 2014
The European Medicines Agency (EMA) has issued an alert to healthcare professionals across the European Union after being informed that vials of the cancer medicine Herceptin (trastuzumab), thought to have been stolen in Italy, including from hospitals, have been tampered with and re-introduced under false credentials into the supply chain in some countries.
Further information is available via the EMA website here: